Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Guardant Health Profit Margin 2017-2019 | GH

Current and historical gross margin, operating margin and net profit margin for Guardant Health (GH) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Guardant Health net profit margin as of September 30, 2019 is -40.99%.
  
Guardant Health Annual Profit Margins
Guardant Health Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.811B $0.091B
Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health Inc. is based in REDWOOD CITY, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.221B 16.15
CSL (CSLLY) Australia $87.693B 0.00
Gilead Sciences (GILD) United States $85.562B 10.60
Vertex Pharmaceuticals (VRTX) United States $56.714B 57.89
Biogen (BIIB) United States $53.023B 9.10
Illumina (ILMN) United States $47.333B 51.93
Regeneron Pharmaceuticals (REGN) United States $40.861B 17.89
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.889B 12.29
Incyte (INCY) United States $20.000B 46.42
Seattle Genetics (SGEN) United States $19.240B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.114B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.532B 0.00
Genmab (GNMSF) Denmark $13.473B 59.51
Alnylam Pharmaceuticals (ALNY) United States $13.447B 0.00
Galapagos (GLPG) Belgium $11.816B 30.44
Exact Sciences (EXAS) United States $11.090B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.822B 51.94
QIAGEN (QGEN) Netherlands $9.359B 30.51
BeiGene (BGNE) Cayman Islands $8.604B 0.00
Bio-Techne Corp (TECH) United States $8.320B 55.69
Amarin (AMRN) Ireland $8.212B 0.00
Sarepta Therapeutics (SRPT) United States $7.489B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.857B 0.00
BioNTech SE (BNTX) Germany $6.752B 0.00
Medicines (MDCO) United States $6.699B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.151B 15.64
Moderna (MRNA) United States $6.148B 0.00
Reata Pharmaceuticals (RETA) United States $6.086B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.943B 0.00
Exelixis (EXEL) United States $5.363B 15.09
Ascendis Pharma (ASND) Denmark $4.958B 0.00
Bluebird Bio (BLUE) United States $4.651B 0.00
Repligen (RGEN) United States $4.640B 84.08
China Biologic Products (CBPO) China $4.594B 25.88
MorphoSys AG (MOR) Germany $4.535B 0.00
Spark Therapeutics (ONCE) United States $4.259B 0.00
Mirati Therapeutics (MRTX) United States $4.185B 0.00
Immunomedics (IMMU) United States $4.008B 0.00
Adaptive Biotechnologies (ADPT) United States $3.938B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.795B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.645B 0.00
Blueprint Medicines (BPMC) United States $3.629B 0.00
Alkermes (ALKS) Ireland $3.347B 0.00
MyoKardia (MYOK) United States $3.017B 0.00
UniQure (QURE) Netherlands $3.005B 0.00
Genmab (GMAB) Denmark $2.859B 5.89
Emergent Biosolutions (EBS) United States $2.789B 27.71
NeoGenomics (NEO) United States $2.779B 147.89
Halozyme Therapeutics (HALO) United States $2.743B 0.00
Acceleron Pharma (XLRN) United States $2.650B 0.00
Zai Lab (ZLAB) China $2.500B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.468B 0.00
Amicus Therapeutics (FOLD) United States $2.423B 0.00
Arena Pharmaceuticals (ARNA) United States $2.371B 5.52
RA PHARMCTL INC (RARX) United States $2.232B 0.00
Insmed (INSM) United States $2.067B 0.00
Ligand Pharmaceuticals (LGND) United States $1.876B 36.10
Myriad Genetics (MYGN) United States $1.860B 27.47
Akcea Therapeutics (AKCA) United States $1.830B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.829B 0.00
Denali Therapeutics (DNLI) United States $1.799B 0.00
Zymeworks (ZYME) Canada $1.688B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.667B 0.00
Principia Biopharma (PRNB) United States $1.625B 0.00
Epizyme (EPZM) United States $1.622B 0.00
REGENXBIO (RGNX) United States $1.546B 0.00
Editas Medicine (EDIT) United States $1.546B 0.00
Arvinas (ARVN) United States $1.456B 0.00
Fate Therapeutics (FATE) United States $1.430B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.395B 0.00
Innoviva (INVA) United States $1.386B 4.08
Alector (ALEC) United States $1.374B 0.00
Athenex (ATNX) United States $1.315B 0.00
Coherus BioSciences (CHRS) United States $1.280B 0.00
WAVE Life Sciences (WVE) Singapore $1.247B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.088B 0.00
Pharming Group (PHGUF) Netherlands $1.025B 0.00
Sangamo Therapeutics (SGMO) United States $1.006B 0.00
Zealand Pharma (ZEAL) Denmark $0.992B 0.00
Codexis (CDXS) United States $0.926B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.918B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.906B 7.61
Achillion Pharmaceuticals (ACHN) United States $0.870B 0.00
Twist Bioscience (TWST) United States $0.861B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.838B 0.00
Intellia Therapeutics (NTLA) United States $0.822B 0.00
Vericel (VCEL) United States $0.794B 296.17
MiMedx (MDXG) United States $0.791B 0.00
DBV Technologies S.A (DBVT) France $0.780B 0.00
Anika Therapeutics (ANIK) United States $0.763B 24.77
ANI Pharmaceuticals (ANIP) United States $0.749B 12.77
Revance Therapeutics (RVNC) United States $0.742B 0.00
Clovis Oncology (CLVS) United States $0.736B 0.00
Heska (HSKA) United States $0.733B 187.20
UROGEN PHARMA (URGN) United States $0.698B 0.00
Intra-Cellular Therapies (ITCI) United States $0.691B 0.00
Sorrento Therapeutics (SRNE) United States $0.686B 0.00
Cellectis S.A (CLLS) France $0.678B 0.00
Adverum Biotechnologies (ADVM) United States $0.678B 0.00
Mesoblast (MESO) Australia $0.664B 0.00
Cara Therapeutics (CARA) United States $0.656B 0.00
GENFIT S.A (GNFT) France $0.624B 0.00
Kadmon Holdings (KDMN) United States $0.615B 0.00
Retrophin (RTRX) United States $0.594B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
AC Immune SA (ACIU) Switzerland $0.590B 13.64
PHARMA MAR SA (PHMMF) Spain $0.584B 0.00
BioDelivery Sciences (BDSI) United States $0.578B 0.00
Cytokineticsorporated (CYTK) United States $0.572B 0.00
Dynavax Technologies (DVAX) United States $0.548B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.539B 3.73
Agenus (AGEN) United States $0.526B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.522B 0.00
Prothena (PRTA) Ireland $0.517B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Stemline Therapeutics (STML) United States $0.511B 0.00
Precision BioSciences (DTIL) United States $0.496B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AnaptysBio (ANAB) United States $0.439B 0.00
Avid Bioservices (CDMO) United States $0.413B 0.00
Arcus Biosciences (RCUS) United States $0.410B 0.00
Merus (MRUS) Netherlands $0.402B 0.00
PDL BioPharma (PDLI) United States $0.392B 9.80
Bellus Health (BLU) Canada $0.389B 0.00
OSMOTICA PHARM (OSMT) United States $0.384B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.384B 0.00
Gritstone Oncology (GRTS) United States $0.368B 0.00
Puma Biotechnology (PBYI) United States $0.362B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.362B 0.00
Pfenex (PFNX) United States $0.353B 0.00
Starpharma Holdings (SPHRY) Australia $0.331B 0.00
CytomX Therapeutics (CTMX) United States $0.323B 0.00
Cellular Biomedicine (CBMG) United States $0.322B 0.00
Kindred Biosciences (KIN) United States $0.322B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.319B 0.00
Scholar Rock Holding (SRRK) United States $0.311B 0.00
Seres Therapeutics (MCRB) United States $0.305B 0.00
Geron (GERN) United States $0.300B 0.00
Kamada (KMDA) Israel $0.297B 8.67
MannKind (MNKD) United States $0.289B 0.00
Compugen (CGEN) Israel $0.287B 0.00
Cue Biopharma (CUE) United States $0.285B 0.00
Exicure (XCUR) United States $0.277B 0.00
Inovio Pharmaceuticals (INO) United States $0.271B 0.00
Cel-Sci (CVM) United States $0.267B 0.00
Albireo Pharma (ALBO) United States $0.266B 0.00
IVERIC Bio (ISEE) United States $0.264B 0.00
Sutro Biopharma (STRO) United States $0.259B 0.00
Senesco Technologies (ELOX) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.246B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.240B 0.00
ChromaDex (CDXC) United States $0.235B 0.00
Theratechnologies (THTX) Canada $0.232B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.231B 0.00
Biofrontera AG (BFRA) Germany $0.221B 0.00
NantKwest (NK) United States $0.216B 0.00
Proteostasis Therapeutics (PTI) United States $0.210B 0.00
Spero Therapeutics (SPRO) United States $0.209B 0.00
Abeona Therapeutics (ABEO) United States $0.204B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
XOMA (XOMA) United States $0.202B 0.00
Athersys (ATHX) United States $0.202B 0.00
Protagonist Therapeutics (PTGX) United States $0.199B 0.00
Syros Pharmaceuticals (SYRS) United States $0.196B 0.00
Cerecor (CERC) United States $0.194B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.190B 0.00
Affimed (AFMD) Germany $0.190B 0.00
ARAVIVE, INC (ARAV) United States $0.190B 0.00
Palatin Technologies (PTN) United States $0.186B 5.06
Mersana Therapeutics (MRSN) United States $0.183B 0.00
VBI Vaccines (VBIV) United States $0.176B 0.00
Five Prime Therapeutics (FPRX) United States $0.170B 0.00
CorMedix Inc (CRMD) United States $0.165B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.163B 0.00
Alcobra (ARCT) United States $0.162B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.158B 0.00
Windtree Therapeutics (WINT) United States $0.144B 0.00
Aptinyx (APTX) United States $0.142B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.139B 0.00
Fortress Biotech (FBIO) United States $0.138B 0.00
Arsanis (XFOR) United States $0.136B 0.00
Arbutus Biopharma (ABUS) Canada $0.136B 0.00
Northwest Biotherapeutics (NWBO) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Prometic Life Sciences (LMNL) Canada $0.132B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.130B 0.00
TELA Bio (TELA) United States $0.128B 0.00
Nicox SA (NICXF) France $0.125B 0.00
Enzo Biochem (ENZ) United States $0.122B 0.00
SESEN BIO, INC (SESN) United States $0.114B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.113B 0.00
PHASEBIO PHARMA (PHAS) United States $0.111B 0.00
Celyad SA (CYAD) Belgium $0.107B 0.00
Menlo Therapeutics (MNLO) United States $0.106B 0.00
Novavax (NVAX) United States $0.106B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.103B 0.00
BioTime (LCTX) United States $0.103B 5.28
Verastem (VSTM) United States $0.101B 0.00
Strongbridge Biopharma (SBBP) United States $0.099B 2.65
Aduro Biotech (ADRO) United States $0.095B 0.00
Acorda Therapeutics (ACOR) United States $0.088B 0.00
Antibe Therapeutics (ATBPF) Canada $0.088B 0.00
Synlogic (SYBX) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
OvaScience (MLND) United States $0.084B 0.00
Emmaus Life Sciences (EMMA) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
Selecta Biosciences (SELB) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Trevena (TRVN) United States $0.071B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.068B 0.00
Organovo Holdings (ONVO) United States $0.066B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.065B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.060B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Catalyst Biosciences (CBIO) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.055B 0.00
Curis (CRIS) United States $0.051B 0.00
Applied Genetic Technologies (AGTC) United States $0.049B 0.00
Checkpoint Therapeutics (CKPT) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.047B 0.00
Orgenesis (ORGS) United States $0.045B 2.92
AquaBounty Technologies (AQB) United States $0.044B 0.00
Alimera Sciences (ALIM) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.041B 0.00
Protalix BioTherapeutics (PLX) Israel $0.041B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
Evogene (EVGN) Israel $0.039B 0.00
AIT Therapeutics (XAIR) United States $0.039B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Stellar Biotechnologies (EDSA) Canada $0.034B 0.00
Oncobiologics (OTLK) United States $0.032B 0.00
Apricus Biosciences (SEEL) United States $0.031B 0.00
VIVUS (VVUS) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
BioCardia (BCDA) United States $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
Novogen (KZIA) Australia $0.028B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Soligenix (SNGX) United States $0.026B 0.00
VistaGen Therapeutics (VTGN) United States $0.025B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
CollPlant Holdings (CLGN) Israel $0.020B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.016B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Advaxis (ADXS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
IBio (IBIO) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.003B 0.00